Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat

Canadian Journal of Physiology and Pharmacology

Volumn 91, Issue 7, 2013, Pages 547-561

  Bourgoin, Frédéric ^a   Bachelard, Hélène ^a   Badeau, Mylène ^a   Larivière, Richard ^a   Nadeau, André ^a   Pitre, Maryse ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cardiometabolic complications; Endothelial dysfunction; HFHS diet; Insulin resistance; Metabolic syndrome; Oxidative stress; Tempol

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIN 1; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; TEMPOL; TRIACYLGLYCEROL;

ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; DRUG EFFECT; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GLUCOSE INFUSION; GLUCOSE INTAKE; GLUCOSE TRANSPORT; HEART RATE; HEMODYNAMICS; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; WHITE ADIPOSE TISSUE;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; BODY MASS INDEX; CYCLIC N-OXIDES; DIET, HIGH-FAT; DIETARY SUCROSE; ENDOTHELIN-1; ENDOTHELINS; ENDOTHELIUM, VASCULAR; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEART RATE; HEMODYNAMICS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SPIN LABELS; TYROSINE;

EID: 84879925491     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2012-0273     Document Type: Article

References (120)

1. Balon, T.W., and Nadler, J.L. 1997. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 82(1): 359-363. PMID:9029239.
2. Barnard, R.J., Roberts, C.K., Varon, S.M., and Berger, J.J. 1998. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J. Appl. Physiol. 84: 1311-1315. PMID:9516198.
3. Baron, A.D. 1996. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes, 45(Suppl. 1): S105-S109. doi:10.2337/diab.45.1.S105. PMID:8529789.
4. Baron, A.D., and Clark, M.G. 1997. Role of blood flow in the regulation of muscle glucose uptake. Annu. Rev. Nutr. 17: 487-499. doi:10.1146/annurev.nutr.17.1. 487. PMID:9240937.
5. Baron, A.D., Zhu, J.-S., Marshall, S., Irsula, O., Brechtel, G., and Keech, C. 1995. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am. J. Physiol. Endocrinol. Metab. 269(32): E709-E715. PMID:7485485.
6. Bédard, S., Marcotte, B., and Marette, A. 1997. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 325: 487-493. PMID:9230132.
7. Boulanger, C., and Luscher, T.F. 1991. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin.Invest. 92: 587-590. doi:10.1172/JCI114477. PMID:215371.
8. Bourgoin, F., Bachelard, H., Badeau, M., Mélançon, S., Pitre, M., Larivière, R., and Nadeau, A. 2008. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am. J. Physiol. Heart Circ. Physiol. 295(3): H1044-H1055. doi:10.1152/ajpheart.00516.2008. PMID:18599593.
9. Brodsky, S.V., Gealekman, O., Chen, J., Zhang, F., Togashi, N., Crabtree, M., Gross, S.S., Nasjletti, A., and Goligorsky, M.S. 2004. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ. Res. 94: 377-384. doi:10.1161/01.RES.0000111802. 09964.EF. PMID:14670841.
10. Caballero, A.E. 2005. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch. Med. Res. 36: 241-249. doi:10.1016/j.arcmed.2005.03.013. PMID:15925014.
11. Cai, H., and Harrison, D.G. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87: 840-844 doi:10.1161/01.RES.87. 10.840. PMID:11073878.
12. Carvalho-Filho, M.A., Ropelle, E.R., Pauli, R.J., Cintra, D.E., Tsukumo, D.M., and Silveira, L.R. 2009. Aspirin attenuates insulin resistance in muscle of dietinduced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia, 52: 2425-2434.doi:10.1007/s00125-009-1498-1. PMID:19730809.
13. Carvalho-Filho, M.A., Ueno, M., Carvalheira, J.B., Velloso, L.A., and Saad, M.J. 2006. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab. 291: E476-E482. doi:10.1152/ajpendo.00422.2005. PMID: 16638822.
14. Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B., and de Oliveira, M.G. et al. 2005. S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 54: 959-967. doi:10.2337/diabetes.54.4.959. PMID: 15793233.
15. Ceriello, A., and Motz, E. 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24: 816-823.doi:10.1161/01.ATV.0000122852.22604.78. PMID:14976002.
16. Cersosimo, E., and DeFronzo, R.A. 2006. Insulin resistance and endothelial dysfunction: the road map to CV diseases. Diabetes Metab. Res. Rev. 22: 423-436. doi:10.1002/dmrr.634. PMID:16506274.
17. Chander, P.N., Gealekman, O., Brodsky, S.V., Elitok, S., Tojo, A., Crabtree, M., Gross, S.S., and Goligorsky, M.S. 2004. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J. Am. Soc. Nephrol. 15: 2391-2403. doi:10.1097/01.ASN.0000135971.88164.2C. PMID:15339988.
18. Chang, C.J., Wu, J.S., Lu, F.H., Liu, I.M., Chi, T.C., and Cheng, J.T. 1998. Sympathetic hyperactivity in Wistar rats with insulin-resistance. J. Auton. Nerv. Syst. 74(2-3): 116-119. doi:10.1016/S0165-1838(98)00143-X. PMID:9915626.
19. Balon, T.W., and Nadler, J.L. 1997. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 82(1): 359-363. PMID:9029239.
20. Barnard, R.J., Roberts, C.K., Varon, S.M., and Berger, J.J. 1998. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J. Appl. Physiol. 84: 1311-1315. PMID:9516198.
21. Baron, A.D. 1996. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes, 45(Suppl. 1): S105-S109. doi:10.2337/diab.45.1.S105. PMID:8529789.
22. Baron, A.D., and Clark, M.G. 1997. Role of blood flow in the regulation of muscle glucose uptake. Annu. Rev. Nutr. 17: 487-499. doi:10.1146/annurev.nutr.17.1. 487. PMID:9240937.
23. Baron, A.D., Zhu, J.-S., Marshall, S., Irsula, O., Brechtel, G., and Keech, C. 1995. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am. J. Physiol. Endocrinol. Metab. 269(32): E709-E715. PMID:7485485.
24. Bédard, S., Marcotte, B., and Marette, A. 1997. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 325: 487-493. PMID:9230132.
25. Boulanger, C., and Luscher, T.F. 1991. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin.Invest. 92: 587-590. doi:10.1172/JCI114477. PMID:215371.
26. Bourgoin, F., Bachelard, H., Badeau, M., Mélançon, S., Pitre, M., Larivière, R., and Nadeau, A. 2008. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am. J. Physiol. Heart Circ. Physiol. 295(3): H1044-H1055. doi:10.1152/ajpheart.00516.2008. PMID:18599593.
27. Brodsky, S.V., Gealekman, O., Chen, J., Zhang, F., Togashi, N., Crabtree, M., Gross, S.S., Nasjletti, A., and Goligorsky, M.S. 2004. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ. Res. 94: 377-384. doi:10.1161/01.RES.0000111802. 09964.EF. PMID:14670841.
28. Caballero, A.E. 2005. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch. Med. Res. 36: 241-249. doi:10.1016/j.arcmed.2005.03.013. PMID:15925014.
29. Cai, H., and Harrison, D.G. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87: 840-844. doi:10.1161/01.RES.87. 10.840. PMID:11073878.
30. Carvalho-Filho, M.A., Ropelle, E.R., Pauli, R.J., Cintra, D.E., Tsukumo, D.M., and Silveira, L.R. 2009. Aspirin attenuates insulin resistance in muscle of dietinduced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia, 52: 2425-2434.doi:10.1007/s00125-009-1498-1. PMID:19730809.
31. Carvalho-Filho, M.A., Ueno, M., Carvalheira, J.B., Velloso, L.A., and Saad, M.J. 2006. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab. 291: E476-E482. doi:10.1152/ajpendo.00422.2005. PMID: 16638822.
32. Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B., and de Oliveira, M.G. et al. 2005. S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 54: 959-967. doi:10.2337/diabetes.54.4.959. PMID: 15793233.
33. Ceriello, A., and Motz, E. 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24: 816-823.doi:10.1161/01.ATV.0000122852.22604.78. PMID:14976002.
34. Cersosimo, E., and DeFronzo, R.A. 2006. Insulin resistance and endothelial dysfunction: the road map to CV diseases. Diabetes Metab. Res. Rev. 22: 423-436. doi:10.1002/dmrr.634. PMID:16506274.
35. Chander, P.N., Gealekman, O., Brodsky, S.V., Elitok, S., Tojo, A., Crabtree, M., Gross, S.S., and Goligorsky, M.S. 2004. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J. Am. Soc. Nephrol. 15: 2391-2403. doi:10.1097/01.ASN.0000135971.88164.2C. PMID:15339988.
36. Chang, C.J., Wu, J.S., Lu, F.H., Liu, I.M., Chi, T.C., and Cheng, J.T. 1998. Sympathetic hyperactivity in Wistar rats with insulin-resistance. J. Auton. Nerv. Syst. 74(2-3): 116-119. doi:10.1016/S0165-1838(98)00143-X. PMID:9915626.
37. Balon, T.W., and Nadler, J.L. 1997. Evidence that nitric oxide increases glucose transport in skeletal muscle. J. Appl. Physiol. 82(1): 359-363. PMID:9029239.
38. Barnard, R.J., Roberts, C.K., Varon, S.M., and Berger, J.J. 1998. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J. Appl. Physiol. 84: 1311-1315. PMID:9516198.
39. Baron, A.D. 1996. The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes, 45(Suppl. 1): S105-S109. doi:10.2337/diab.45.1.S105. PMID:8529789.
40. Baron, A.D., and Clark, M.G. 1997. Role of blood flow in the regulation of muscle glucose uptake. Annu. Rev. Nutr. 17: 487-499. doi:10.1146/annurev.nutr.17.1. 487. PMID:9240937.
41. Baron, A.D., Zhu, J.-S., Marshall, S., Irsula, O., Brechtel, G., and Keech, C. 1995. Insulin resistance after hypertension induced by the nitric oxide synthesis inhibitor L-NMMA in rats. Am. J. Physiol. Endocrinol. Metab. 269(32): E709-E715. PMID:7485485.
42. Bédard, S., Marcotte, B., and Marette, A. 1997. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase. Biochem. J. 325: 487-493. PMID:9230132.
43. Boulanger, C., and Luscher, T.F. 1991. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J. Clin.Invest. 92: 587-590. doi:10.1172/JCI114477. PMID:215371.
44. Bourgoin, F., Bachelard, H., Badeau, M., Mélançon, S., Pitre, M., Larivière, R., and Nadeau, A. 2008. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am. J. Physiol. Heart Circ. Physiol. 295(3): H1044-H1055. doi:10.1152/ajpheart.00516.2008. PMID:18599593.
45. Brodsky, S.V., Gealekman, O., Chen, J., Zhang, F., Togashi, N., Crabtree, M., Gross, S.S., Nasjletti, A., and Goligorsky, M.S. 2004. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ. Res. 94: 377-384. doi:10.1161/01.RES.0000111802. 09964.EF. PMID:14670841.
46. Caballero, A.E. 2005. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation. Arch. Med. Res. 36: 241-249. doi:10.1016/j.arcmed.2005.03.013. PMID:15925014.
47. Cai, H., and Harrison, D.G. 2000. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87: 840-844. doi:10.1161/01.RES.87. 10.840. PMID:11073878.
48. Carvalho-Filho, M.A., Ropelle, E.R., Pauli, R.J., Cintra, D.E., Tsukumo, D.M., and Silveira, L.R. 2009. Aspirin attenuates insulin resistance in muscle of dietinduced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia, 52: 2425-2434.doi:10.1007/s00125-009-1498-1. PMID:19730809.
49. Carvalho-Filho, M.A., Ueno, M., Carvalheira, J.B., Velloso, L.A., and Saad, M.J. 2006. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am. J. Physiol. Endocrinol. Metab. 291: E476-E482. doi:10.1152/ajpendo.00422.2005. PMID: 16638822.
50. Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B., and de Oliveira, M.G. et al. 2005. S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes, 54: 959-967. doi:10.2337/diabetes.54.4.959. PMID: 15793233.
51. Ceriello, A., and Motz, E. 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24: 816-823.doi:10.1161/01.ATV.0000122852.22604.78. PMID:14976002.
52. Cersosimo, E., and DeFronzo, R.A. 2006. Insulin resistance and endothelial dysfunction: the road map to CV diseases. Diabetes Metab. Res. Rev. 22: 423-436. doi:10.1002/dmrr.634. PMID:16506274.
53. Chander, P.N., Gealekman, O., Brodsky, S.V., Elitok, S., Tojo, A., Crabtree, M., Gross, S.S., and Goligorsky, M.S. 2004. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J. Am. Soc. Nephrol. 15: 2391-2403. doi:10.1097/01.ASN.0000135971.88164.2C. PMID:15339988.
54. Chang, C.J., Wu, J.S., Lu, F.H., Liu, I.M., Chi, T.C., and Cheng, J.T. 1998. Sympathetic hyperactivity in Wistar rats with insulin-resistance. J. Auton. Nerv. Syst. 74(2-3): 116-119. doi:10.1016/S0165-1838(98)00143-X. PMID:9915626.
55. Christon, R., Marette, A., Badeau, M., Bourgoin, F., Melancon, S., and Bachelard, H. 2005. Fatty acid-induced changes in vascular reactivity in healthy adult rats. Metabolism, 54(12): 1600-1609. doi:10.1016/j.metabol.2005. 06.007. PMID:16311092.
56. Clark, M.G., Wallis, M.G., Barrett, E.J., Vincent, M.A., Richards, S.M., Clerk, L.H., and Rattigan, S. 2003. Blood flow and muscle metabolism: a focus on insulin action. Am. J. Physiol. 284: E241-E258. doi:10.1152/ajpendo.00408.2002. PMID: 12531739.
57. Cook, S., Hugli, O., Egli, M., Vollenweider, P., Burcelin, R., Nicod, P., Thorens, B., and Scherrer, U. 2003. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med. Wkly. 133: 360-363. PMID:12947532.
58. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., and Garg, R. 2005. Metabolic syndrome. A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation, 111: 1448-1454. doi:10.1161/01. CIR.0000158483.13093.9D. PMID:15781756.
59. Desbuquois, B., and Aurbach, G.D. 1971. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 33(5): 732-738. doi:10.1210/jcem-33-5-732. PMID:5166455.
60. Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., and Scherrer, U. 2001. Insulin resistance, hyperinsulinemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation, 104: 342-345. doi:10.1161/01.CIR. 104.3.342. PMID:11457755.
61. Etgen, G.J., Fryburg, D.A., and Gibbs, E.M. 1997. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes, 46: 1915-1919. doi:10.2337/diabetes.46.11.1915. PMID:9356048.
62. Frisbee, J.C. 2005. Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R307-R316. doi:10.1152/ajpregu.00114. 2005. PMID:15802560.
63. Galili, O., Versari, D., Sattler, K.J., Olson, M.L., Mannheim, D., McConnell, J.P., Chade, A.R., Lerman, L.O., and Lerman, A. 2007. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am. J. Physiol. 292: H904-H911. doi:10.1152/ajpheart.00628.2006. PMID:17012356.
64. Gardiner, S.M., and Bennett, T. 1988. Regional haemodynamic responses to adrenoceptor antagonism in conscious rats. Am. J. Physiol. 255: H813-H824. PMID:2902805.
65. Greenacre, S.A., and Ischiropoulos, H. 2001. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34: 541-581. doi:10.1080/10715760100300471. PMID:11697033.
66. Griendling, K., Sorescu, D., and Ushio-Fukai, M. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86: 494-501. doi:10.1161/01.RES. 86.5.494. PMID:10720409.
67. Guarino, M.P., and Macedo, M.P. 2006. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br. J. Pharmacol. 147: 959-965. doi:10.1038/sj.bjp.0706691. PMID:16491098.
68. Guarino, M.P., Correia, N.C., Lautt, W.W., and Macedo, M.P. 2004. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G527-G532. doi:10.1152/ajpgi. 00085.2004. PMID:15331351.
69. Gupte, A.A., Bomhoff, G.L., Morris, J.K., Gorres, B.K., and Geiger, P.C. 2009. Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats. J. Appl. Physiol. 106: 1425-1434. doi:10.1152/japplphysiol.91210.2008. PMID: 19179648.
70. Hansen, P.A., Gulve, E.A., and Holloszy, J.O. 1994. Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. J. Appl. Physiol. 76(2): 979-985. PMID:8175614.
71. Hasdan, G., Benchetrit, S., Rashid, G., Green, J., Bernheim, J., and Rathaus, M. 2002. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int. 61: 586-590. doi:10.1046/j. 1523-1755.2002.00166.x. PMID:11849400.
72. Haugaard, N., and Haugaard, E.S. 1970. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim. Biophys. Acta, 222(3): 583-586. doi:10.1016/0304-4165(70)90183-2. PMID:4924865.
73. Henriksen, E.J., Jacob, S., Streeper, R.S., Fogt, D.L., Hokama, J.Y., and Tritschler, H.J. 1997. Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci. 61: 805-812. doi:10. 1016/S0024-3205(97)00562-6. PMID:9275010.
74. Higaki, Y., Hirshman, M.F., Fujii, N., and Goodyear, L.J. 2001. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes, 50: 241-247. doi: 10.2337/diabetes.50.2.241. PMID:11272132.
75. Ischiropoulos, H. 1998. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356: 1-11. doi:10.1006/abbi.1998.0755. PMID:9681984.
76. Jacob, S., Streeper, R.S., Fogt, D.L., Hokama, J.Y., Tritschler, H.J., Dietze, G.J., and Henriksen, E.J. 1996. The antioxidant alpha-lipoic acid enhances insulinstimulated glucose metabolism in insulin-resistant skeletal muscle. Diabetes, 45: 1024-1029. doi:10.2337/diabetes.45.8.1024. PMID:8690147.
77. Kaufman, L.N., Peterson, M.M., and Smith, S.M. 1991. Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am. J. Physiol. 260(1): E95-E100. PMID:1987797.
78. Khamaisi, M., Potashnik, R., Tirosh, A., Demshchak, E., Rudich, A., Tritschler, H., Wessel, K., and Bashan, N. 1997. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism, 46: 763-768. doi:10.1016/S0026-0495(97)90120-7. PMID:9225829.
79. Kim, J., Montagnani, M., Koh, K.K., and Quon, M.J. 2006. Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation, 113: 1888-1904. doi:10.1161/ CIRCULATIONAHA.105.563213. PMID:16618833.
80. Kohlmeier, M. 1986. Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin.Chem. 32(1): 63-66. PMID:3510098.
81. Kuboki, K., Jiang, Z.Y., Takahara, N., Ha, S.W., Igarashi, M., Yamauchi, T., Feener, E.P., Herbert, T.P., Rhodes, C.J., and King, G.L. 2000. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo. A specific vascular action of insulin. Circulation, 101: 676-681. doi:10.1161/01.CIR.101.6.676. PMID:10673261.
82. Laakso, M., Edelman, S.V., Brechtel, G., and Baron, A.D. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J. Clin. Invest. 85: 1844-1852. doi:10.1172/JCI114644. PMID:2189893.
83. Laakso, M., Edelman, S., Brechtel, G., and Baron, A.D. 1992. Impaired insulin mediated skeletal muscle blood flow in patients with NIDDM. Diabetes, 41: 1076-1083. doi:10.2337/diabetes.41.9.1076. PMID:1499861.
84. Mather, K., Laakso, M., Edelman, S., Hook, G., and Baron, A. 2000. Evidence for physiological coupling of insulin-mediated glucose metabolism and limb blood flow. Am. J. Physiol. Endocrinol. Metab. 279: E1264-E1270. PMID: 11093913.
85. McIntyre, M., Bohr, D., and Dominiczak, A. 1999. Endothelial function in hypertension: the role of superoxyde anion. Hypertension, 34: 539-545. doi:10.1161/ 01.HYP.34.4.539. PMID:10523323.
86. Mélançon, S., Bachelard, H., Badeau, M., Bourgoin, F., Pitre, M., Larivière, R., and Nadeau, A. 2006. Effects of high-sucrose feeding on insulin resistance and hemodynamic responses to insulin in spontaneously hypertensive rats. Am. J. Physiol. 290(6): H2571-H2581. PMID:16443676.
87. Mohanty, P., Ghanim, H., Hamouda, W., Aljada, A., Garg, R., and Dandona, P. 2002. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am. J. Clin. Nutr. 75: 767-772. PMID:11916766.
88. Perreault, M., and Marette, A. 2001. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nature Med. 7(10): 1138-1143. doi:10.1038/nm1001-1138. PMID:11590438.
89. Pilon, G., Charbonneau, A., White, P.J., Dallaire, P., Perreault, M., Kapur, S., and Marette, A. 2012. Endotoxin mediated-iNOS induction causes insulin resistance via ONOO2 induced tyrosine nitration of IRS-1 in skeletal muscle. Plos One, 5(12). doi:10.1371/journal.pone.0015912. PMID:21206533.
90. Pitre, M., Nadeau, A., and Bachelard, H. 1996. Insulin sensitivity and hemodynamic responses to insulin in Wistar-Kyoto and spontaneously hypertensive rats. Am. J. Physiol. Endocrinol. Metab. 271(34): E658-E668. PMID:8897853.
91. Pitre, M., Santuré, M., Lévesque, M., Nadeau, A., and Bachelard, H. 2000. Implication du NO dans les effets vasculaires et métaboliques de l'insuline. Médecine Sciences, 16(Suppl. 1): 28.
92. Richard, V., Hogie, M., Clozel, M., Loffler, B.M., and Thuillez, C. 1995. In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation, 91: 771-775. doi:10.1161/01.CIR.91.3.771. PMID:7828305.
93. Richterich, R., and Dauwalder, H. 1971. Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method [In German]. Schweiz. Med. Wochenschr. 101(17): 615-618. PMID:5576952.
94. Rizvi, A.A. 2007. Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome and type 2 diabetes. Clin.Med. J. 120(21): 1918-1924.
95. Roberts, C.K., Barnard, R.J., Sindhu, R.K., Jurczak, M., Ehdaie, A., and Vaziri, N.D. 2005. A high-fat, refined-carbohydrate diet induces endothelial dysfunction, oxydant/antioxidant imbalance and depresses NOS protein expression. J. Appl. Physiol. 98(1): 203-210. PMID:15333612.
96. Roberts, C.K., Vaziri, N.D., Wang, X.Q., and Barnard, R.J. 2000. Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension, 36: 423-429. doi:10.1161/01.HYP.36.3.423. PMID:10988276.
97. Roy, D., Perreault, M., and Marette, A. 1998. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am. J. Physiol. 274: E692-E699. PMID:9575831.
98. Saengsirisuwan, V., Perez, F.R., Sloniger, J.A., Maier, T., and Henriksen, E.J. 2004. Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats. Am. J. Physiol. Endocrinol. Metab. 287(3): E529-E536. doi:10.1152/ajpendo.00013.2004. PMID:15068957.
99. Santuré, M., Pitre, M., Marette, A., Deshaies, Y., Lemieux, C., Larivière, R., Nadeau, A., and Bachelard, H. 2002. Induction of insulin resistance by highsucrose feeding does not raise mean arterial blood pressure but impairs hemodynamic responses to insulin in rats. Br. J. Pharmacol. 137(2): 185-196.doi:10.1038/sj.bjp.0704864. PMID:12208775.
100. Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L., and Nicod, P. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin.Invest. 94: 2511-2515. doi:10.1172/JCI117621. PMID:7989610.
101. Schnackenberg, C.G., Welch, W.J., and Wilcox, C.S. 1998. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension, 32: 59-64.doi:10.1161/01.HYP.32.1.59. PMID:9674638.
102. Shinozaki, K., Kashiwagi, A., Nishio, Y., Okamura, T., Yoshida, Y., Masada, M., Toda, N., and Kikkawa, R. 1999. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/ O2-imbalance in insulin-resistant rat aorta. Diabetes, 48: 2437-2445. doi:10. 2337/diabetes.48.12.2437. PMID:10580434.
103. Shokoji, T., Nishiyama, A., Fujisawa, Y., Hitomi, H., Kiyomoto, H., Takahashi, M., Kimura, S., Kohno, M., and Abe, Y. 2003. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension, 41: 266-273.doi:10.1161/01.HYP.0000049621.85474.CF. PMID:12574093.
104. Simonsen, U., Christensen, F.H., and Buus, N.H. 2009. The effect of tempol on endothelium-dependent vasodilatation and blood pressure. Pharmacol. Ther. 122: 109-124. doi:10.1016/j.pharmthera.2009.02.002. PMID:19268689.
105. Somers, M.J., Mavromatis, K., Galis, Z.S., and Harrison, D.G. 2000. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation, 101: 1722-1728. doi:10.1161/01. CIR.101.14.1722. PMID:10758056.
106. Stamler, J.S., Singel, D.J., and Loscalzo, J. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science, 258(5090): 1898-1902. doi:10.1126/science. 1281928. PMID:1281928.
107. Steinberg, H.O., Brechtel, G., Johnson, A., Fineberg, N., and Baron, A.D. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94: 1172-1179. doi:10.1172/JCI117433. PMID:8083357.
108. Thannickal, V., and Fanburg, B.L. 2000. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L1005-L1028. PMID:11076791.
109. Tracy, R.P. 2003. Inflammation, the metabolic syndrome and cardiovascular risk. Int. J. Clin.Pract. Suppl. 134: 10-17. PMID:12793593.
110. Vincent, M.A., Barrett, E., Lindner, J.R., Clark, M.G., and Rattigan, S. 2003. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin.Am. J. Physiol. 285: E123-E129. doi:10.1152/ ajpendo.00021.2003. PMID:12791603.
111. Vincent, M.A., Clerk, L.H., Lindner, J.R., Klibanov, A.L., Clark, M.G., Rattigan, S., and Barrett, E.J. 2004. Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes, 53: 1418-1423. doi:10.2337/diabetes.53.6.1418. PMID:15161743.
112. Wilcox, C.S. 2010. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol. Ther. 126(2): 119-145. doi:10.1016/j.pharmthera. 2010.01.003. PMID:20153367.
113. Wilcox, C.S., and Pearlman, A. 2008. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol. Rev. 60(4): 418-469. doi:10.1124/pr. 108.000240. PMID:19112152.
114. Wilson, P.W.F., D'Agostino, R.B., Parise, H., Sullivan, L., and Meigs, J.B. 2005. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112: 3066-3072. doi:10.1161/CIRCULATIONAHA.105. 539528. PMID:16275870.
115. Woodman, O.L., Malakul, W., Cao, A.H., Xu, Q., and Ritchie, R.H. 2008. Atrial natriuretic peptide prevents diabetes-induced endothelial dysfunction. Life Sci. 82(15-16): 847-854. doi:10.1016/j.lfs.2008.01.016. PMID:18302965.
116. Xu, H., Fink, G.D., and Galligam, J.J. 2004. Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in Doca-salt rats. Hypertension, 43: 329-334. doi:10.1161/01.HYP.0000112304.26158.5c. PMID:14707156.
117. Young, J.B., and Walgren, M.C. 1994. Differential effects of dietary fats on sympathetic nervous system activity in the rat. Metabolism, 43(1): 51-60. doi:10. 1016/0026-0495(94)90157-0. PMID:8289676.
118. Young, M.E., Radda, G.K., and Leighton, B. 1997. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 322: 223-228. PMID:9078265.
119. Zeng, G., Nystrom, F.H., Ravichandran, L.V., Cong, L.-N., Kirby, M., Mostowski, H., and Quon, M.J. 2000. Role for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation, 101: 1539-1545. doi:10.1161/01. CIR.101.13.1539. PMID:10747347.
120. Zheng, J.S., Yang, X.Q., Lookingland, K.J., Fink, G.D., Hesslinger, C., Kapatos, G., Kovesdi, I., and Chen, A.F. 2003. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase 1 restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation, 108: 1238-1245. doi:10.1161/01.CIR.0000089082.40285.C3. PMID: 12925450.